Summary
Transgenic mice overexpressing the three major neuronal isoforms of the human amyloid precursor protein (APP), APP695, APP751, APP770 may provide an animal model for the analysis of the mechanisms and risk factors leading to amyloid deposition in Alzheimer’s disease (AD) and Downs syndrome (DS). We have therefore generated transgenic mice expressing these isoforms under the control of the strong metallothionin promoter. Although we can demonstrate expression of transgenic APP in several tissues including brain, expression levels never exceeded those of the endogenous mouse APP. So far we have not been able to detect pathological changes resembling those of AD and DS. However we could demonstrate significant changes in spatial navigation tasks and motor behavior in the transgenic mice. The question remains open whether overexpression of APP is sufficient to induce Alzheimer pathology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Banati RB, Gehrmann J, Czech C, Mönning U, Jones LL, König G, Masters CL, Beyreuther K, Kreutzberg GW (1993) Early and rapid denovo synthesis of Alzheimer βA4 amyloid precursor protein (APP) in activated mircoglia. Glia 9: 199–210
Brinster RL, Allen JM, Behringer RE, Gelinas RE, Palmiter RD (1988) Introns increase transcriptional efficency in transgenic mice. Proc Natl Acad Sci USA 85: 836–840
Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993) Generation of beta- amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90: 2092–2096
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo PC, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672–674
Clark M, Gagnon J, William AF, Barclay AN (1985) MRC Ox-2 antigen: a lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobuline light chain. EMBO J 4: 113–118
Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688–1693
Dyrks T, Dyrks E, Masters CL, Beyreuther K (1993) Amyloidogenicity of rodent and human ßA4 sequences. FEBS 324: 231–235
Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267: 18210–18217
Gage FH, Björklund A, Stenevi U, Dunnett SB, Kelly PAT (1984) Intrahippocampal septal grafts ameliorate learning impairments in aged rats. Science 225: 533–536
Glenner GG, Wong (1984) Alzheimer’s disease: inital report of the purification and characterisation of a novel cerebrovascular amyloid protein. C.M. Biochem Biophys Res Commun 120: 885
Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357: 500–503
Hilbich C, Kisters WB, Reed J, Masters CL, Beyreuther K (1991) Human and rodent sequence analogs of Alzheimer’s amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem 201: 61–69
Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL (1992) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89: 10857–10861
Kang J, Muller HB (1990) Differential splicing of Alzheimer’s disease amyloid A4 precursor RNA in rat tissues: Pre A4 (695) RNA is predominantly produced in rat and human brain. Biochem Biophys Res Commun 166: 1192–1200
Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller HB (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733–736
Karin M, Richards RI (1982) Human metallothionine genes-primary structure of metallothionine-II gene and a related processed gene. Nature 299: 797–802
Kawabata S, Higgins GA, Gordon JW (1991) Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein [retracted by Kawabata S, Higgins GA, Gordon JW. In: Nature 356: 23 (1992) and Nature 356: 265 (1992) [see comments]. Nature 354: 476–478
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331: 530–532
König G, Mönning U, Czech C, Prior R, Banati R, Schreiter GU, Bauer J, Masters CL, Beyreuther K (1992) Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem 267: 10804–10809
König G, Salbaum JM, Wiestier O, Lang W, Schmitt HP, Masters CL, Beyreuther K (1991) Alternative splicing of the beta A4 amyloid gene of Alzheimer’s disease in cortex of control and Alzheimer’s disease patients. Brain Res Mol Brain Res 9: 259–262
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680
Lamp BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (1993) Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Gene 5: 22–29
Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4: 2757–2763
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer’s disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249
Methali M, LeMeur M, Lathe R (1990) The methylation-free status of a housekeeping transgene is lost at high copy number. Gene 91: 179–184
Monning U, Konig G, Banati RB, Mechler H, Czech C, Gehrmann J, Schreiter GU, Masters CL, Beyreuther K (1992) Alzheimer beta A4-amyloid protein precursor in immunocompetent cells. J Biol Chem 267: 23950–23956
Morris RGM (1981) Learn Motiv 12: 239 - 249
Mullan M, Crawford F (1993) Genetic and molecular advances in Alzheimer’s disease. TINS 16: 398–403
Miiller HB, Beyreuther K (1989) Molecular biology of Alzheimer’s disease. Annu Rev Biochem 58: 287–307
Neve RL, Finch EA, Bird ED, Benowitz LI (1988) Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc Natl Acad Sci USA 85: 638–642
Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL (1991) Hetero; logous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci USA 88: 478–482
Patterson D, Gardiner K, Kao FT, Tanzi R, Watkins P, Gusella JF (1988) Mapping of the gene encoding the beta-amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21. Proc Natl Acad Sci USA 85: 8266–8270
Ponte P, Gonzalez DP, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331: 525–527
Price DL (1986) New perspectives on Alzheimer’s disease. Annu Rev Neurosci 9: 489–512
Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352: 239–241
Richards SJ, Waters JJ, Beyreuther K, Masters CL, Wischik CM, Sparkman DR, White CI, Abraham CR, Dunnett SB (1991) Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer’s disease neuropathology. Embo J 10: 297–303
Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL (1989) Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease. N Engl J Med 320: 1446–1452
Sandbrink R, Master CL, Beyreuther K (1994) 0A4-Amyloid protein precursor mRNA isoforms without exon 15 ( L-APP mRNAs) are ubiquitously expressed in rat tissues including brain, but not in neurons. J Cell Biol 261: 1510–1517
Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC (1990) Overexpression of TGFa in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121–1135
Sandhu FA, Salim M, Zain SB (1991) Expression of the human beta-amyloid protein of Alzheimer’s disease specifically in the brains of transgenic mice. J Biol Chem 266: 21331–21334
Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer’s disease. Science 235: 873–877
Seubert P, Vigo PC, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, et al (1992) Isolation and quantification of soluble Alzheimer’s beta-peptide from biological fluids [see comments]. Nature 359: 325–327
Shivers BD, Hilbich C, Multhaup G, Salbaum M, Beyreuther K, Seeburg PH (1988) Alzheimer’s disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. Embo J 7: 1365–1370
Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, et al (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258: 126–129
Struble RG, Price DL Jr, Cork LC, Price DL (1985) Senile plaques in cortex of aged normal monkeys. Brain Res 361: 267–275
Tanzi RE, McClatchey AI, Lamperti ED, Villa KL, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature 331: 528–530
von Braunmuhl A (1956) Arch Psychiat Z Neurol 194: 396–414
Weidemann A, Konig G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57: 115–126
Whishaw IQ, O’Conner WT, Dunnett SB (1985) Behav Brain Res 17: 103–115
Wirak DO, Bayney R, Ramabhadran TV, Fracasso RP, Hart JT, Hauer PE, Hsiau P, Pekar SK, Scangos GA, Trapp BD, et al (1991) Deposits of amyloid beta protein in the central nervous system of transgenic mice [see comments]. Science 253: 323–325
Wisniewski HM, Johnson AB, Raine CS, Kay WJ, Terry RD (1970) Lab Invest 23: 287–296
Yamada T, Sasaki H, Furuya H, Miyata T, Goto I, Sakaki Y (1987) Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. Biochem Biophys Res Commun 149: 665–671
Yamaguchi F, Richards SJ, Beyreuther K, Salbaum M, Carlson GA, Dunnett SB (1991) Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2: 781–784
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag
About this paper
Cite this paper
Czech, C., Masters, C., Beyreuther, K. (1994). Alzheimer’s disease and transgenic mice. In: Hoyer, S., Müller, D., Plaschke, K. (eds) Cell and Animal Models in Aging and Dementia Research. Journal of Neural Transmission, vol 44. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9350-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9350-1_17
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82549-5
Online ISBN: 978-3-7091-9350-1
eBook Packages: Springer Book Archive